Search results for "pharmaceutical company"

Kyungbo Pharmaceutical Passes U.S. FDA On-Site Inspection at Asan Plant

Kyungbo Pharmaceutical Passes U.S. FDA On-Site Inspection at Asan Plant

Kyungbo Pharmaceutical announced on the 18th that it passed an on-site manufacturing inspection by the U. S.
Daewoong Pharmaceutical to Build Aseptic Manufacturing Facility for Semaglutide Microneedle Patch

Daewoong Pharmaceutical to Build Aseptic Manufacturing Facility for Semaglutide Microneedle Patch

Daewoong Pharmaceutical is accelerating efforts to secure Good Manufacturing Practice approval and establish an automated quality-control...
From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro

From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro

Efpeglenatide, a drug candidate whose development rights were once returned by a global pharmaceutical giant, is...
Hanmi Pharmaceutical Unveils Next-Gen Cancer Tech Targeting Tumor Microenvironment

Hanmi Pharmaceutical Unveils Next-Gen Cancer Tech Targeting Tumor Microenvironment

Hanmi Pharmaceutical has unveiled a next-generation cancer technology designed to deliver drugs to the tumor...
Daewoong Pharmaceutical Enters Digital Therapeutics Market with Exclusive Deal for MCI Device 'Cogthera'

Daewoong Pharmaceutical Enters Digital Therapeutics Market with Exclusive Deal for MCI Device 'Cogthera'

Daewoong Pharmaceutical announced on the 22nd that it has signed an exclusive domestic sales and commercialization...
Daewoong Pharmaceutical Nears Completion of Phase 2 IPF Trial for Bersiporosin, Readout Set for H1 2027

Daewoong Pharmaceutical Nears Completion of Phase 2 IPF Trial for Bersiporosin, Readout Set for H1 2027

Daewoong Pharmaceutical has completed patient enrollment for the global Phase 2 clinical trial of bersiporosin...
Exclusive: Boryung’s Spun-Off Sales Unit Sets Pay Above Parent Levels, Top 40% Eligible for 100 Million-Plus Won

Exclusive: Boryung’s Spun-Off Sales Unit Sets Pay Above Parent Levels, Top 40% Eligible for 100 Million-Plus Won

Boryung is setting compensation at its soon-to-be spun-off prescription drug sales division above parent-company...
Hanmi Group Unveils ‘Anne’ Character to Unify Popular OTC Brand Lineup

Hanmi Group Unveils ‘Anne’ Character to Unify Popular OTC Brand Lineup

Sore-throat spray "Mok-Anne" and artificial tear formula "Nun-Anne"—two familiar over-the-counter products in South...
Samsung Biologics to Raise ₩3 Trillion in Rights Offering to Fund ₩2.7 Trillion Acquisition of PolyPeptide Group

Samsung Biologics to Raise ₩3 Trillion in Rights Offering to Fund ₩2.7 Trillion Acquisition of PolyPeptide Group

Samsung Biologics is proceeding with a 3 trillion won ($2.25 billion) rights offering, directing approximately 90% of...
Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion

Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion

Celltrion is stepping up efforts to identify and foster promising biotech startups in Japan.